J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pruzanski, W.
Right arrow Articles by Kuksis, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pruzanski, W.
Right arrow Articles by Kuksis, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 41, 1035-1047, July 2000
Copyright © 2000 by Lipid Research, Inc.


Original Article

Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins

W. Pruzanskia, E. Stefanskia, F. C. de Beerc, M. C. de Beerc, A. Ravandib, and A. Kuksisb
a Inflammation Research Group, University of Toronto, Toronto, Canada M4Y 1J3
b Banting and Best Department of Medical Research, University of Toronto, Toronto, Canada M4Y 1J3
c Veterans Affairs Medical Center, Lexington, KY 40536

Correspondence to: W. Pruzanski

In the acute-phase response and in diseases with prolonged acute phases, normal HDL (NHDL) is converted into acute-phase HDL (APHDL) and becomes proinflammatory and unable to protect LDL against oxidative modification. Earlier work had demonstrated that these changes are associated with alterations in apolipoprotein composition and enzymatic activity of APHDL, but the effect of the acute-phase condition on the lipid composition of APHDL had remained obscure. The present study shows marked quantitative differences in lipid composition between NHDL and APHDL. Specifically, APHDL contained 25% less total lipid per milligram of protein. Up to 50% of cholesteryl ester in the lipid core of APHDL was replaced by triacylglycerol; however, the total phospholipid/total neutral lipid ratios were the same as in NHDL, both lipoproteins giving similar calculated lipid core radii. Furthermore, the phosphatidylcholine/sphingomyelin ratio in APHDL was nearly double that in NHDL, indicating a relative loss of sphingomyelin. A decrease was also seen in diacyl and alkenylacyl glycerophosphatidylethanolamine as well as in phosphatidylinositol of APHDL when compared with NHDL. APHDL contained proportionally more saturated and less polyunsaturated and isoprostane-containing species of phosphatidylcholine, as well as more saturated than unsaturated cholesteryl esters. APHDL also contained significantly more free fatty acids, lysophosphatidylcholine, and free cholesterol.

These changes in the lipid composition of HDL are consistent with the alterations in the apoprotein composition and enzymatic activity of APHDL and indicate proinflammatory and proatherogenic roles for APHDL.—Pruzanski, W., E. Stefanski, F. C. de Beer, M. C. de Beer, A. Ravandi, and A. Kuksis. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J. Lipid Res. 2000. 41: 1035–1047.

Supplementary key words: normal and acute phase, high density lipoprotein, lipid composition, functional impact


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. I. van Leuven, R. Hezemans, J. H. Levels, S. Snoek, P. C. Stokkers, G. K. Hovingh, J. J. P. Kastelein, E. S. Stroes, E. de Groot, and D. W. Hommes
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease
J. Lipid Res., December 1, 2007; 48(12): 2640 - 2646.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Y. Han, T. Chiba, J. S. Campbell, N. Fausto, M. Chaisson, G. Orasanu, J. Plutzky, and A. Chait
Reciprocal and Coordinate Regulation of Serum Amyloid A Versus Apolipoprotein A-I and Paraoxonase-1 by Inflammation in Murine Hepatocytes
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1806 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
P. Aspichueta, B. Perez-Agote, S. Perez, B. Ochoa, and O. Fresnedo
Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver
Innate Immunity, June 1, 2006; 12(3): 181 - 191.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
P. Aspichueta, S. Perez, B. Ochoa, and O. Fresnedo
Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver
J. Lipid Res., May 1, 2005; 46(5): 1017 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke
Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
J. Lipid Res., March 1, 2005; 46(3): 389 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. A. Kaysen and J. P. Eiserich
The Role of Oxidative Stress-Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 538 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. C. Hudgins, T. S. Parker, D. M. Levine, B. R. Gordon, S. D. Saal, X.-c. Jiang, C. E. Seidman, J. D. Tremaroli, J. Lai, and A. L. Rubin
A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers
J. Lipid Res., August 1, 2003; 44(8): 1489 - 1498.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. Tiemeier, H R. van Tuijl, A. Hofman, A. J Kiliaan, and M. M. Breteler
Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study
Am. J. Clinical Nutrition, July 1, 2003; 78(1): 40 - 46.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Liebisch, W. Drobnik, B. Lieser, and G. Schmitz
High-Throughput Quantification of Lysophosphatidylcholine by Electrospray Ionization Tandem Mass Spectrometry
Clin. Chem., December 1, 2002; 48(12): 2217 - 2224.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. Petrovic, C. Grove, P. E. Langton, N. L. A. Misso, and P. J. Thompson
A simple assay for a human serum phospholipase A2 that is associated with high-density lipoproteins
J. Lipid Res., October 1, 2001; 42(10): 1706 - 1714.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.